13 June 1997
Cellula radhesion molecules changes in myocardium during first year post heart transplant
M Zembala, R Wojnicz, J Wojarski, J Nozynski, P Knapik, J Bialkowski, J Foremny, M RozekAnn Transplant 1997; 2(2): 16-19 :: ID: 497149
Abstract
The increased presence of intercellular adhesion molecule-I (ICAM-I) and vascular adhesion molecule-I (VCAM-I) in the myocardium after orthotropic heart transplantation (OHT) has been implicated in early and late organ rejection. The aim of this study was to investigate the changes in ICAM-1 and VCAM-I during the first years post-OHT. Accordingly. we studied multiple endomyocardiaJ biopsy specimens collected from II randomly selected patients (all males, mean age 46:t II years). Qualification criteria for OHT included: ischemic cardiomyopathy in 6 pts (55%) and idiopathic dilated cardiomyopathy in 5 pts (45%). All patients were receiving triple immunosuppressive regimen. The therapy consisted of cyclosporine, azathioprine, and prednisolone. Multiple endomyocardial biopsy specimens were collected at 7, 30, 90 and 360 days post OHT from all patients (pts), and examined routinely for histologic signs of organ rejection. To assess levels of adhesion molecules we used monoclonal antibodies (murine anti-human ICAM-1 and VCAM-I) on frozen sections. Immunoreactivity (IR) was detected using a commercially available kit. Intensity of IRwas assessed based on a semiquantitative scoring system. In this study, IR scores 2:2 + were considered positive for ICAM-I, and scores 2: I + were considered positive for VCAM-I. IR scores in specimens obtained from consecutive biopsies were compared with the initial biopsy collected at the day 7. The results were analyzed using nonparametric statistics. The routine evaluation revealed histological signs of organ rejection (2:2) in 2 pts at 7 days, in 5 pts at 30 days, in 3 pts at 90 days, and in I patient at 360 days. On the other hand, ICAM-1 and VCAM-I expression were absent in the majority of patients at 7, 30 and 90 days, but their presence was significantly increased at 360 days (p
Keywords: renal transplantation, acute renal failure, acute tubular necrosis, acute rejection, CyclosporinA
In Press
15 Mar 2024 : Review article
Approaches and Challenges in the Current Management of Cytomegalovirus in Transplant Recipients: Highlighti...Ann Transplant In Press; DOI: 10.12659/AOT.941185
18 Mar 2024 : Original article
Does Antibiotic Use Increase the Risk of Post-Transplantation Diabetes Mellitus? A Retrospective Study of R...Ann Transplant In Press; DOI: 10.12659/AOT.943282
20 Mar 2024 : Original article
Transplant Nephrectomy: A Comparative Study of Timing and Techniques in a Single InstitutionAnn Transplant In Press; DOI: 10.12659/AOT.942252
28 Mar 2024 : Original article
Association Between FEV₁ Decline Rate and Mortality in Long-Term Follow-Up of a 21-Patient Pilot Clinical T...Ann Transplant In Press; DOI: 10.12659/AOT.942823
Most Viewed Current Articles
05 Apr 2022 : Original article
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
12 Jan 2022 : Original article
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
22 Nov 2022 : Original article
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
15 Mar 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860